Endo Pill Mix-up Prompts Recall

Some of the prescription pills produced by Endo Pharmaceuticals, the Chadds Ford company that will soon relocate its headquarters to East Whiteland, might have slipped into incorrect bottles, according to recent news reports.

From CNN:

Machinery problems at a drug manufacturing plant prompted the U.S. Food and Drug Administration to warn patients of a possible mix-up affecting various prescription pain medications and over-the-counter drugs.

The FDA is advising patients who use certain prescription medications produced by Endo Pharmaceuticals to visually inspect their pills. And consumers who have select bottles of Excedrin, Bufferin, NoDoz and Gas-X, produced by Novartis, are being told to discard or return the products in a voluntary recall that started Sunday.

From Endo's press release, titled "Supply Shortage and Rare Tablet Mix-up":

For patients currently prescribed any of the following products, a visual guide (PDF) has been provided to verify the appearance of these products. Please review the product name of your prescription to confirm the tablets in your prescription match the tablet images provided:

• OPANA® ER (oxymorphone hydrochloride) Extended-Release Tablets CII
• OPANA® (oxymorphone hydrochloride) Tablets CII
• Oxymorphone Hydrochloride Tablets CII
• PERCOCET® (oxycodone hydrochloride and acetaminophen USP) Tablets CII
• PERCODAN® (oxycodone hydrochloride and aspirin, USP) Tablets CII
• ENDOCET® (oxycodone hydrochloride and acetaminophen USP) Tablets CII
• ENDODAN® (oxycodone hydrochloride and aspirin, USP) Tablets CII
• Morphine Sulfate Extended-Release Tablets CII
• ZYDONE® (hydrocodone bitartrate/acetaminophen tablets, USP) CIII